KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.

BULLISH Impact: 2/10 ANALYST-UPGRADE
Processed 1mo ago SEC analyst-KMTS-btig-20251118
6 firms acted on KMTS: BTIG, Wolfe Research, Wells Fargo, Stifel, Goldman Sachs, Piper Sandler
Latest settled — T+20d
KMTS ▲ +5.10% at T+20d
LONG call ✓ call won +5.10% · α vs SPY -0.72% · entry $20.41 → $21.45
Next anchor: T+60d in 4w
Currently $20.85 · +2.16% from $20.41 entry
Entry anchored
Apr 16, 03:58 PM ET
via Databento tick
T+1d
+11.76%
call +11.76% · α +10.54%
$22.81
settled 8w ago
T+5d
+11.32%
call +11.32% · α +10.33%
$22.72
settled 7w ago
T+20d
+5.10%
call +5.10% · α -0.72%
$21.45
settled 4w ago
T+60d
call — · α —
in 4w

Price Chart

Loading chart...

Executive Summary

BTIG initiated coverage on KMTS with a Buy rating and $32 price target, the highest among seven analysts, implying 59% upside from the current $20.05. Consensus target is $28.71 with median at $30; KMTS trades below all but Goldman Sachs’ $17 PT. BTIG has a 53% accuracy rate (503/948) and average return of 3.7%, slightly below top-tier firms. No upgrades or downgrades in past 30 days, but EPS estimates show minor upward revisions over 7-day horizon. Goldman Sachs, Wells Fargo, and Piper Sandler maintain Overweight/Neutral ratings with mixed track records—Goldman at 0% accuracy (0/3), Wells at 33% (1/3), Piper at 0% (0/2). Insider activity is split: $200K buy by COHEN RAYMOND W vs $304K sell by Webster Brian Daniel. No congressional trades or institutional changes reported. Earnings date not disclosed; no imminent catalyst flagged.

Impact Score

Base Score
1/7
LLM Adjustment
+1
Final Score
2/10

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-04-09 Goldman Sachs maintain Neutral $17.00
2026-04-07 BTIG reiterate Buy $32.00
2026-03-25 BTIG reiterate Buy
2026-03-18 BTIG reiterate Buy
2025-12-15 Goldman Sachs maintain Neutral $25.00
2025-12-12 Wells Fargo maintain Overweight $28.00
2025-12-12 Piper Sandler maintain Overweight $30.00
2025-11-18 BTIG initiate Buy $32.00
2025-07-17 Wells Fargo maintain Overweight $27.00
2025-04-16 Goldman Sachs maintain Neutral $23.00

No analyst upgrades or downgrades in the past 30 days. EPS revisions show minimal movement: 1 upward revision each in 7-day and 30-day windows, no downward revisions in past 7 days, but 1 down revision in past 30 days across all periods. Estimates remain stable: current 0Y EPS at -2.33, down from -2.315 30 days ago, indicating slight deterioration despite recent upward tweaks.

Firm Track Record — BTIG

BTIG accuracy: 53% on 948 calls | avg return: 3.7%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 3 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Wells Fargo 33% 1/3 -4.8% below average
Goldman Sachs 0% 0/3 -34% below average
Piper Sandler 0% 0/2 -31.9% below average

BTIG has a 53% accuracy rate (503 correct out of 948 rated stocks) with an average return of 3.7%, placing it slightly below the top-performing firms. Among peers covering KMTS, Wells Fargo has 33% accuracy (1/3), Goldman Sachs 0% (0/3), and Piper Sandler 0% (0/2)—all below average. BTIG is the most credible firm on record, though not elite.

Earnings Estimates

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0y $-2.33 $-2.36 — $-2.30 $93.0M ↑1 ↓0
+1q $-0.54 $-0.55 — $-0.53 $28.0M ↑1 ↓0
+1y $-2.14 $-2.37 — $-1.91 $132.9M ↑1 ↓0
0q $-0.58 $-0.61 — $-0.55 $26.5M ↑1 ↓0

Cross-Platform Signals

Insider Trades (90d)
1 buys / 1 sells

Insider activity is mixed: $199.8K buy by COHEN RAYMOND W on 2026-03-26 contrasts with $304.1K sell by Webster Brian Daniel on 2026-03-17. No congressional trades, institutional position changes, or short interest data available. Insider signal diverges from analyst sentiment—executive selling offsets minor buying, weakening confirmation of bullish thesis.

Actionable Insight

BTIG’s initiation offers a high-conviction bullish entry point with strong upside potential, supported by the highest price target and relatively better firm accuracy. Favorable EPS revision trends and majority Buy consensus justify long positioning, but lack of earnings catalyst and mixed insider signals warrant cautious entry.

Documents Analyzed

Report based on filing metadata.

5 reports for KMTS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for KMTS — sortable, filterable
Type Now
May 16, 2026
27d ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$25.65 $26.82▲ +4.56%▲ +2.26%$20.85 (−18.71%)
Apr 16, 2026
8w ago
ANALYST-UPGRADE
BULLISH ★ 2/10
$20.41 $21.45▲ +5.10%▼ −0.72%$20.85 (+2.16%)
Apr 1, 2026
10w ago
S-3ASR
NEUTRAL ★ 3/10
$19.84 $20.72▲ +4.44%▼ −5.44%$20.85 (+5.09%)
Mar 17, 2026
12w ago
Press Release
BULLISH ★ 8/10
$19.58 $20.41▲ +4.24%▼ −1.81%$20.85 (+6.49%)
Mar 3, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$22.92 $19.93▼ −13.05%▼ −8.64%$20.85 (−9.03%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (47h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access